LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | GR_AOC |
---|---|---|
Hs 578T | HG-6-64-01 | 0.5227 |
Hs 578T | Imatinib | -0.0158 |
Hs 578T | JNK-9L | 0.4183 |
Hs 578T | JW-7-24-1 | 0.4056 |
Hs 578T | KIN001-043 | 0.0667 |
Hs 578T | Lapatinib | 0.0496 |
Hs 578T | LDN-193189 | 0.3463 |
Hs 578T | Linifanib | 0.0569 |
Hs 578T | Linsitinib | 0.0529 |
Hs 578T | Mitoxantrone | 1.1623 |
Hs 578T | MK2206 | 0.3187 |
Hs 578T | Neratinib | 0.4706 |
Hs 578T | Nilotinib | 0.0332 |
Hs 578T | Nintedanib | 0.3775 |
Hs 578T | NU7441 | 0.2381 |
Hs 578T | NVP-AEW541 | 0.0745 |
Hs 578T | Luminespib | 0.9219 |
Hs 578T | NVP-TAE684 | 0.5941 |
Hs 578T | OSI-027 | 0.3952 |
Hs 578T | Palbociclib | 0.5293 |
Hs 578T | PD0325901 | 0.7224 |
Hs 578T | PD173074 | 0.2327 |
Hs 578T | PD184352 | 0.4227 |
Hs 578T | Pelitinib | 0.2873 |
Hs 578T | PF431396 | 0.5981 |